文献速递淋巴瘤

探索Castleman病与TAFRO综合征的临床多样性:日本多中心关于淋巴结分布模式的研究

Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns.
PubMed 文献 · Am J Hematol · 2025-01-25

日本多中心回顾性研究分析321例Castleman病(CD)与TAFRO综合征患者,探讨肿大淋巴结的数量和位置能否预测临床进展与严重程度。结果显示TAFRO综合征患者在各淋巴结区域计数范围内均可见淋巴结肿大,而CD患者无论是否合并TAFRO综合征,受累淋巴结区域数量与特定临床模式无关。

要点

  • TAFRO综合征患者在各淋巴结区域计数范围内均可见淋巴结肿大。
  • CD患者无论是否合并TAFRO综合征,受累淋巴结区域数量与特定临床模式无关。
  • 作者认为全面临床评估而非仅依赖淋巴结计数对管理这些疾病至关重要。

核心结论

  • 淋巴结数量不能预测CD和TAFRO综合征的临床进展和强度,全面临床评估而非仅依赖淋巴结计数对有效管理这些疾病至关重要。
  • 需要额外研究来确定可靠的诊断标志物并在诊断时预测疾病严重程度,最终改善患者结局。

研究设计与样本

  • 日本多中心回顾性研究,纳入321例Castleman病(CD)和TAFRO综合征患者,分析肿大淋巴结的数量和位置与临床进展及严重程度的关系。

主要发现

  • TAFRO综合征患者在各淋巴结区域计数范围内均可见淋巴结肿大。
  • CD患者无论是否合并TAFRO综合征,受累淋巴结区域数量与特定临床模式无关。

局限性

  • 需要额外研究来确定可靠的诊断标志物并在诊断时预测疾病严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Individuals diagnosed with Castleman disease (CD) and TAFRO syndrome (characterized by thrombocytopenia, anasarca, fever, bone marrow fibrosis, and organomegaly) displays a wide range of clinical symptoms, including varying patterns of lymph node enlargement, systemic inflammation, and impaired organ function. Some patients may present with both CD and TAFRO syndrome concurrently. A retrospective study conducted across multiple centers in Japan examined 321 cases to determine if the quantity and position of swollen lymph nodes could forecast the clinical progression and intensity of these conditions. Interestingly, the study revealed that patients with TAFRO syndrome exhibited lymphadenopathy across all ranges of lymph node region counts. Moreover, no specific clinical patterns were associated with the number of affected lymph node regions in CD patients, regardless of whether they also had TAFRO syndrome. These results enhance our understanding of the clinical variability in CD and TAFRO syndrome, suggesting that a comprehensive clinical evaluation, rather than relying solely on lymph node count, is crucial for effectively managing these conditions. Additional studies are required to establish reliable diagnostic markers and to predict disease severity at the time of diagnosis, ultimately improving patient outcomes.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Otsuka M, Koga T, Sumiyoshi R, et al. Exploring the Clinical Diversity of Castleman Disease and TAFRO Syndrome: A Japanese Multicenter Study on Lymph Node Distribution Patterns. Am J Hematol. 2025. PMID: 39865257. doi:10.1002/ajh.27612

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。